Authors
Latest:
Infection Control: AP Technology's Impact on Reducing HAIs and AMR PathogensDeborah Birx, MD, and Amy Carenza, BBA, highlight the targeting of multidrug-resistant organisms and tracking of infection trends without increasing staffing needs.
Latest:
COVID-19 Infection Does Not Impact Symptom Severity or Disability Trajectory in Multiple SclerosisBetween those infected and uninfected with COVID-19, investigators observed no differences in symptom trajectories, assessed through SymptoMScreen.
Latest:
A Novel Approach to Infectious Disease SurveillanceThe International Society for Infectious Diseases (ISID) ProMED surveillance system is a way for clinicians and interested ID stakeholders to be aware of local outbreaks and follow-up in response to get more information on them.
Latest:
Lifting the Medical and Economic Burden of AMR in the USThis bipartisan initiative highlights the need for a comprehensive approach to combat antimicrobial resistance (AMR), incorporating both antibiotic drug development and increased funding for stewardship programs.
Latest:
Dose Optimization as a Strategy to Improve Clinical Outcomes and Suppress Antimicrobial ResistanceFrom the discovery of penicillin to PK-PD principles: A brief historical overview and what we have learned from recent clinical trials.
Latest:
Disseminated Gonococcal Infection Complicated by Suspected Osteomyelitis of Humeral HeadGonococcal septic polyarthritis is an uncommon manifestation of N gonorrhoeae infection, but has increased by about 40% in recent years.
Latest:
Community-Acquired Candida Glabrata Empyema: An Atypical Diagnosis Not to MissAlthough this patient had none of these common risk factors associated with Candida empyema, she did have other factors predisposing her to fungal colonization and subsequent infection.
Latest:
Amoxicillin Treatment for Syphilis: Can an Old Drug Learn a New Trick?With an increased incidence of this sexually transmitted infection, a review of an older antibiotic for treatment has shown some clinical benefits in other countries.
Latest:
Daptomycin as Frontline Therapy for MRSA Bacteremia: Has the Time Come?Findings increasingly suggest the mortality risk may be reduced by initiating daptomycin within 3 days of infection.
Latest:
Practice Pearls for Treatment of Respiratory InfectionsTina Tan, MD; Wendy Wright, DNP, ANP-BC, FNP-BC, FAANP, FAAN, FNAP; Priya Nori, MD; Jacinda Abdul-Mutakabbir, PharmD; and Kevin Michael Reiter, MD, PA, provide key takeaways from the discussion on the treatment of respiratory viral infections.
Latest:
Amped-up Enterobacterales DebateDemystifying clinical data for treating invasive AmpC-harboring Enterobacterales.
Latest:
Impact of Inpatient Pharmacist Review of Discharge AntibioticsA food for thought as an ambulatory antibiotic stewardship initiative.
Latest:
Ready, Set, Cabenuva: Implementing Cabotegravir/RilpivirineThis novel therapeutic option represents the first long-acting injectable approved for maintenance of HIV-1 suppression.
Latest:
Mpox and Concerns Around the Disease in the United StatesScott Bertani, who is the director of Advocacy of the National Coalition for LGBTQ Health, discusses what the new mpox health declarations mean to the US, which groups are high risk, and information about the vaccine to prevent the disease.
Latest:
The Next Generation of COVID-19 Vaccines and BoostersWill there be an answer to keep the continuously evolving virus at bay? Are seasonal combination vaccines the wave of the future?
Latest:
RSV Prophylaxis: Palivizumab, Nirsevimab, and MoreCurrent prevention strategies include two injectables for infants and young children, namely palivizumab and nirsevimab.
Latest:
Hepatitis B Vaccination Increases Survival of Patients with Chronic Liver DiseaseHepatitis B virus vaccination shown to to significantly improve survival rates for patients with chronic hepatitis C, nonalcoholic liver disease, and liver cirrhosis.
Latest:
Barriers to Health Care Transition in Adolescents and Young Adults With Early Acquired HIV InfectionUnique challenges can affect the success of the shift from pediatric to adult care settings.
Latest:
Tips for Talking with Patients about Fecal Microbiota Transplant for Recurrent C. difficile InfectionsTo close the discussion, experts on C. difficile infections discuss how they talk with patients about fecal microbiota transplantation.
Latest:
Shionogi's Strategies for Addressing Antibiotic Efficacy and ResistanceChristine Slover, PharmD discussed cefiderocol's effectiveness against challenging infections, including those caused by multi-drug resistant bacteria.
Latest:
Science Is Science: Navigating Clinical Trust Amid Political ShiftsSu H Wang, MD, FACP, MPH discusses combating vaccine misinformation, preventing outbreaks, and highlighting global health interconnectedness
Latest:
Unmasking the Infodemic: The Impact of COVID-19 Misinformation on Public HealthSocial media platforms, public health agencies, and communities must join forces to stop the rapid spread of false information.
Latest:
New Fecal Microbiota Options for Prevention of Recurrent Clostridioides difficileWith the addition of 2 new live biotherapeutic products, a clinician reviews the application, storage and administration techniques for them.
Latest:
Daptomycin as Frontline Therapy for MRSA Bacteremia: Has the Time Come?Findings increasingly suggest the mortality risk may be reduced by initiating daptomycin within 3 days of infection.
Latest:
The Final Antibiotic Symphony: Harmonizing Diagnostic Accuracy with Antibiotic Treatment in Native Joint Septic ArthritisA study underscores the microbial etiology of septic arthritis, which can guide clinicians in minimizing the use of overly broad empiric antibiotics.
Latest:
COVID-19–Associated Fungal Infections During EMCO: Review of Epidemiology, Diagnosis, and PharmacotherapyExamining pharmacological management in COVID-19 patients with ARDS requiring antifungal therapy during extracorporeal life support.
Latest:
Undermining HIV Prevention Now Will Cost Billions LaterThe 15th anniversary of the Affordable Care Act is overshadowed by threats to HIV prevention efforts, including a looming Supreme Court case that could eliminate no-cost access to preexposure prophylaxis and other preventive services. Simultaneously, deep federal cuts and restructuring have destabilized critical public health infrastructure, jeopardizing decades of progress in the fight against HIV.
Latest:
Getting Help from HAL: Applying Machine Learning to Predict Antibiotic ResistanceA pair of experts assess literature on the means of interpreting hospitalized patient antibiotic resistance through machine learning.
Latest:
Pfizer’s RSVpreF Vaccine Shows Efficacy in High-Risk Adults Aged 18-59Study results show that the vaccine elicits a comparable immune response in high-risk adults aged 18-59 with chronic medical conditions, suggesting potential for broader vaccination efforts.
